Phase 2 Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with a body mass index (BMI) of 30 or above but below 40 (this is a common measure of body weight relative to height)
- People with an HbA1c level below 6.5% (this is a blood test result that shows average blood sugar levels over the past few months)
Who may not be able to join:
- People with a significant ongoing health condition, illness, or unusual test results that could affect their safety or make the trial results harder to interpret
- People who are currently taking medications for long-term weight management or for controlling blood sugar levels
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Medical Director, Alnylam Pharmaceuticals
Phone: 1-877-ALNYLAM
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Part A: Frequency of Adverse Events (AEs); Part B: Percent Change from Baseline in Body Weight; Part C: Percent Change from Baseline in Body Weight
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.